Nature Search

The Baghdad Pact Nuclear Training Centre

JOHN COCKCROFT
Research11 May 1957
Nature

Volume: 179, P: 936
National identity predicts public health support during a global pandemic

Understanding collective behaviour is an important aspect of managing the pandemic response. Here the authors show in a large global study that participants that reported identifying more strongly with their nation reported greater engagement in public health behaviours and support for public health policies in the context of the pandemic.

Jay J. Van Bavel
Aleksandra Cichocka
Paulo S. Boggio
ResearchOpen Access26 Jan 2022
Nature Communications

Volume: 13, P: 1-14
Retrospect

JOHN COCKCROFT
Research16 Sept 1967
Nature

Volume: 215, P: 1228-1229
Radiological Hazards from Nuclear Explosions and Nuclear Power

JOHN COCKCROFT
Research21 May 1955
Nature

Volume: 175, P: 873-875
The δ- and ε-chains of the human T3/T-cell receptor complex are distinct polypeptides

Jannie Borst
John E. Coligan
Cox Terhorst
Research29 Nov 1984
Nature

Volume: 312, P: 455-458
Atomic Energy and its Biological Implications

JOHN COCKCROFT
Research13 Jul 1957
Nature

Volume: 180, P: 64-67
Experiments on the High-Energy Nucleons and Quanta

JOHN COCKCROFT
Research22 Dec 1951
Nature

Volume: 168, P: 1060-1064
Community-specific guidance for environmental sustainability in particle accelerators

Particle accelerators are large-scale, complex projects, and they have some unique challenges when it comes to environmental sustainability. A group of particle accelerator researchers and environmental sustainability experts shares how community-specific guidance can help address these needs.

Hannah Wakeling
Philip Burrows
John Thomason
Comments & Opinion25 Sept 2025
Nature Reviews Physics

P: 1-2
Swelling of Fibrous Proteins

JOHN L. MORRISON
JAMES F. HANLAN
Research09 Mar 1957
Nature

Volume: 179, P: 528-529
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial

In this phase 1 trial of a personalized, neoantigen-specific autologous T cell therapy, BNT221, when given as monotherapy in patients with metastatic melanoma refractory to PD-1 and CTLA-4 inhibitor regimens, the therapy was safe and showed preliminary clinical activity and neoantigen-specific T cell responses.

Jessica S. W. Borgers
Divya Lenkala
Marit M. van Buuren
ResearchOpen Access03 Jan 2025
Nature Medicine

Volume: 31, P: 881-893
Sandy bottom communities at the end of a cold (1971-1975) and warm (1997-1998) regime in the California Current: impacts of high and low plankton production

John Oliver
Stacy Kim
Ethan Barnes
ResearchOpen Access22 Jul 2008
Nature Precedings

P: 1
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

We evaluate the effects in humans of interleukin-15 co-expression on glypican-3 (GPC3) chimeric antigen receptor (CAR) T cells and demonstrate that IL-15 increases the expansion, intratumoural survival and antitumour activity of GPC3 (expressed in a group of solid cancers) CAR T cells.

David Steffin
Nisha Ghatwai
Andras Heczey
Research27 Nov 2024
Nature

Volume: 637, P: 940-946
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

In a phase 1b trial, treatment of patients with muscle-invasive bladder cancer with intravesical oncolytic virus cretostimogene grenadenorepvec in combination with nivolumab was safe and led to encouraging preliminary clinical response rates.

Roger Li
Nancy Y. Villa
Jose R. Conejo-Garcia
Research09 Nov 2024
Nature Medicine

Volume: 31, P: 176-188
Nuclear Physics and Atom Bombs

JOHN COCKCROFT
Books & Arts30 Aug 1958
Nature

Volume: 182, P: 547
Development of the Universe

F. HOYLE
Research14 Jan 1950
Nature

Volume: 165, P: 68-69
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

A neoadjuvant treatment regimen of anti-PD-L1 monotherapy followed by anti-PD-L1 plus chemotherapy was well tolerated and led to a major pathologic response rate of 70% in patients with resectable gastric or gastroesophageal junction adenocarcinoma.

Yara L. Verschoor
Joris van de Haar
Myriam Chalabi
ResearchOpen Access08 Jan 2024
Nature Medicine

Volume: 30, P: 519-530
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Small molecule drugs can affect clearance of monoclonal antibodies, but this hasn’t been assessed for oral HIV-1 pre-exposure prophylaxis. Here, the authors find that faster serum clearance of an experimental IgG1 monoclonal antibody, VRC01, is associated with use of tenofovir-emtricitabine, possibly explained by increased epithelial intestinal permeability.

Yunda Huang
Lily Zhang
Maria P. Lemos
ResearchOpen Access28 Nov 2023
Nature Communications

Volume: 14, P: 1-19
Investment in Science

JOHN COCKCROFT O.M., K.C.B., O.B.E., F.R.S.
Research01 Sept 1962
Nature

Volume: 195, P: 875-880
One man and his lab

John Stachel
Books & Arts05 Jul 1990
Nature

Volume: 346, P: 25-26
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results

In an interim analysis of a phase 1/2 trial, a heterologous prime boost vaccine comprised of a chimpanzee adenovirus and self-amplifying mRNA that encodes neoantigens derived from common oncogenic driver mutations in combination with immune checkpoint blockade was safe and elicited neoantigen-specific T cell responses in patients with advanced solid tumors.

Amy R. Rappaport
Chrisann Kyi
Karin Jooss
Research27 Mar 2024
Nature Medicine

Volume: 30, P: 1013-1022
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

Neoadjuvant combination of immune checkpoint therapy in patients with cisplatin-ineligible bladder cancer achieves clinical efficacy and uncovers immune features as potential predictive biomarkers of treatment response.

Jianjun Gao
Neema Navai
Padmanee Sharma
Research12 Oct 2020
Nature Medicine

Volume: 26, P: 1845-1851
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

The combination of neoadjuvant nivolumab, ipilimumab and chemotherapy showed promising efficacy in patients with resectable non-small cell lung cancer, with higher tumor immune cell infiltration and tertiary lymphoid structures after treatment compared with neoadjuvant nivolumab plus chemotherapy.

Tina Cascone
Cheuk H. Leung
Boris Sepesi
ResearchOpen Access16 Mar 2023
Nature Medicine

Volume: 29, P: 593-604
Isotopic fractionation in meteoritic cadmium

KEVIN J. R. ROSMAN
JOHN R. DE LAETER
Research20 May 1976
Nature

Volume: 261, P: 216-218
Visual Perception of Accelerated Nitrogen Nuclei interacting with the Human Retina

THOMAS F. BUDINGER
JOHN T. LYMAN
CORNELIUS A. TOBIAS
Research22 Sept 1972
Nature

Volume: 239, P: 209-211
Sir Albert Howard, C.I.E

E. JOHN RUSSELL
Comments & Opinion29 Nov 1947
Nature

Volume: 160, P: 741-742
Phosphorylation of c-jun mediated by MAP kinases

Bernd J. Pulverer
John M. Kyriakis
James R. Woodgett
Research17 Oct 1991
Nature

Volume: 353, P: 670-674
Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes

Ernest G. Peralta
Avi Ashkenazi
Daniel J. Capon
Research01 Aug 1988
Nature

Volume: 334, P: 434-437
A road by any other name

John Twin
Correspondence03 Aug 1995
Nature

Volume: 376, P: 381
A road by any other name

John McCauley
Correspondence03 Aug 1995
Nature

Volume: 376, P: 381
Sustainable production of highly conductive multilayer graphene ink for wireless connectivity and IoT applications

Printed conductive inks show promise for future electronic device applications. Here, the authors report synthesis of graphene inks with conductivity of 7.13 × 10^4 S/m by Cyrene assisted liquid phase exfoliation, and their applications in data communication and RF energy harvesting.

Kewen Pan
Yangyang Fan
Zhirun Hu
ResearchOpen Access05 Dec 2018
Nature Communications

Volume: 9, P: 1-10
Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial

Richard et al. perform a clinical trial of anti-TIGIT (T cell immunoreceptor) or anti-LAG3 (lymphocyte activation gene) antibody in combination with pomalidomide and dexamethasone in persons with multiple myeloma and define correlates of response using mass cytometry.

Shambavi Richard
Alexander M. Lesokhin
Madhav V. Dhodapkar
Research26 Aug 2024
Nature Cancer

Volume: 5, P: 1459-1464
The Peaceful Uses of Atomic Energy: The Geneva International Conference

JOHN COCKCROFT
News10 Sept 1955
Nature

Volume: 176, P: 482-484
Barriers and facilitators of translating health research findings into policy in sub-Saharan Africa: A Scoping Review

Florence Upenyu Damba
Ntombifikile Gloria Mtshali
Moses John Chimbari
ReviewsOpen Access28 Feb 2022
Humanities and Social Sciences Communications

Volume: 9, P: 1-15
The Story of the Chemical Elements

JOHN READ
Books & Arts09 Feb 1952
Nature

Volume: 169, P: 209-210
Acceleration in the linear non-scaling fixed-field alternating-gradient accelerator EMMA

Rapid particle acceleration is possible using a fixed-field alternating-gradient machine—but ‘scaling’ in its design has been necessary to avoid beam blow-up and loss. The demonstration now of acceleration in such a machine without scaling has positive implications for future particle accelerators.

S. Machida
R. Barlow
T. Yokoi
Research10 Jan 2012
Nature Physics

Volume: 8, P: 243-247
Anticoagulants in atrial fibrillation patients with chronic kidney disease

Atrial fibrillation and chronic kidney disease (CKD) frequently coexist and confer an increased risk of stroke. Novel anticoagulants are attractive options over warfarin but undergo renal clearance to varying degrees, and therefore require special consideration in patients with CKD. Recent studies also challenge the benefits of warfarin anticoagulation for atrial fibrillation patients undergoing haemodialysis. This Review discusses the data relating to anticoagulation in patients with atrial fibrillation and CKD and highlights the need for further studies to delineate the optimal use of new anticoagulant agents in patients with CKD.

Robert G. Hart
John W. Eikelboom
Charles A. Herzog
Reviews24 Jul 2012
Nature Reviews Nephrology

Volume: 8, P: 569-578
Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid

Neelima Vidula
Sally Greenberg
Hope S. Rugo
ResearchOpen Access06 Sept 2021
npj Breast Cancer

Volume: 7, P: 1-6
Stable laser-acceleration of high-flux proton beams with plasma collimation

Applications of laser-plasma accelerated protons in fundamental, applied and medical sciences crucially depend on the creation of stable collimated beams with high repetition rates. Here the authors demonstrate the generation of multi-MeV protons at 5 Hz, with low (degree-level) proton beam divergence from a laser pulse focused onto a water sheet target, potentially mitigating the need for beam capturing techniques.

M. J. V. Streeter
G. D. Glenn
C. A. J. Palmer
ResearchOpen Access24 Jan 2025
Nature Communications

Volume: 16, P: 1-9
Obituary

JOHN COCKCROFT
Comments & Opinion15 Dec 1962
Nature

Volume: 196, P: 1037-1038
Recent Developments in Nuclear Engineering

JOHN COCKCROFT
News15 Nov 1958
Nature

Volume: 182, P: 1334-1337
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations

Corina Serban
Amirhossein Sahebkar
Maciej Banach
ResearchOpen Access13 May 2015
Scientific Reports

Volume: 5, P: 1-8
The remnants of galaxy formation from a panoramic survey of the region around M31

In hierarchical cosmological models, galaxies grow in mass through the continual accretion of smaller ones. The tidal disruption of these systems is expected to result in loosely bound and distant stars surrounding the galaxy. A panoramic survey of the Andromeda galaxy (M31) now reveals stars and coherent structures that are almost certainly remnants of dwarf galaxies destroyed by the tidal field of M31.

Alan W. McConnachie
Michael J. Irwin
Kimberly A. Venn
Research03 Sept 2009
Nature

Volume: 461, P: 66-69
Emittance preservation in a plasma-wakefield accelerator

High beam quality is key for particle-accelerator applications in high-energy physics and photon science. Here, authors demonstrate gigavolt-per meter acceleration of electron bunches in a plasma-wakefield accelerator with no degradation of emittance, while also preserving charge and energy spread.

C. A. Lindstrøm
J. Beinortaitė
J. Osterhoff
ResearchOpen Access19 Jul 2024
Nature Communications

Volume: 15, P: 1-10
Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial

Marion Thibaudin
Nicolas Roussot
Francois Ghiringhelli
ResearchOpen Access17 Jan 2025
Signal Transduction and Targeted Therapy

Volume: 10, P: 1-13
Lung adenocarcinoma promotion by air pollutants

Combination of epidemiology, preclinical models and ultradeep DNA profiling of clinical cohorts unpicks the inflammatory mechanism by which air pollution promotes lung cancer

William Hill
Emilia L. Lim
Charles Swanton
Research05 Apr 2023
Nature

Volume: 616, P: 159-167
The Timed Up and Go test predicts frailty in patients with COPD

Ali M. Albarrati
Nichola S. Gale
Dennis J. Shale
ResearchOpen Access06 Jul 2022
npj Primary Care Respiratory Medicine

Volume: 32, P: 1-5
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

The heterogeneity of androgen receptor (AR) gene alterations across metastases in prostate cancer remains unresolved. Here, the authors characterise AR genomic complexity across spatially separated lethal metastases from 10 prostate cancer patients and investigate how AR alterations evolve.

A. M. Mahedi Hasan
Paolo Cremaschi
Gerhardt Attard
ResearchOpen Access10 Aug 2023
Nature Communications

Volume: 14, P: 1-16
Death is associated to the type of drug-eluting stent in patients with left ventricular dysfunction and elevated natriuretic peptide levels

Christian Roth
Clemens Gangl
Rudolf Berger
ResearchOpen Access28 Jan 2021
Scientific Reports

Volume: 11, P: 1-10
Sir Winston Churchill K.G., O.M., C.H., F.R.S.

JOHN COCKCROFT
Comments & Opinion01 Jan 1965
Nature

Volume: 205, P: 425
Perchlorate Exposure of the US Population, 2001–2002

Benjamin C Blount
Liza Valentin-Blasini
James L Pirkle
Research18 Oct 2006
Journal of Exposure Science & Environmental Epidemiology

Volume: 17, P: 400-407

Search

Filter By:

Search

Quick links